Chemed Corp (CHE) exhibits 32.5% gross margins and 23.4% return on invested capital within Health Care (Medical/Nursing Services), balanced against a 18.5x enterprise multiple and 7.2% implied options volatility.
Sustained 32.5% gross profitability converts into 13.4% operating margin and 23.4% ROIC, outpacing sector cost of capital.
ROIC: 23.4% // GM: 32.5%YoY revenue trajectory of +65.3% paired with 4.60% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +65.3% // FCF YLD: 4.60%Altman Z-Score of 12.68 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 12.68 // F-SCORE: 7/9Trading at 185.0x trailing P/E (140.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 185.0x // EV/EBITDA: 18.5xOptions market prices a ±7.2% implied move with a 0.73 put/call ratio around $531.00 max pain.
IMPL MOVE: ±7.2% // P/C: 0.73Elevated industry capital intensity and customer concentration in Medical/Nursing Services require continuous execution to defend 0.0% net margins.
NET MARGIN: 0.0% // D/E: 0.24x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CHE & activate live FRED threshold breach alerts.